Global Artificial Intelligence (AI) Pathology Quality Control Market
HealthcareServices

Global Artificial Intelligence (AI) Pathology Quality Control Market Set for Strong Expansion, Reaching $4.64 Billion With 21.1% CAGR by 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai) pathology quality control market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Artificial Intelligence (AI) Pathology Quality Control Market covering 2026–2035?

The artificial intelligence (AI) pathology quality control market size has experienced substantial expansion in recent years. This market is projected to grow from $1.78 billion in 2025 to $2.16 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 21.4%. The growth observed in the historic period can be ascribed to factors such as increasing pathology workload volumes, the early digitization of pathology slides, the growing complexity of cancer diagnostics, the demand for standardized reporting, and the initial adoption of AI-assisted pathology tools.

The artificial intelligence (AI) pathology quality control market is projected to experience rapid expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $4.65 billion, demonstrating a compound annual growth rate (CAGR) of 21.1%. This expansion during the forecast period is primarily driven by factors such as greater investments in digital pathology platforms, a heightened demand for precision diagnostics, the broadening of AI validation within clinical workflows, the increasing integration of pathology data analytics, and a stronger regulatory focus on the quality control of diagnostics. Key trends anticipated over the same period encompass the wider implementation of AI-based slide quality assessment, the growing acceptance of automated error detection instruments, the ongoing standardization of pathology workflows, the extended integration of digital pathology, and a sharpened emphasis on ensuring diagnostic accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28124&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Artificial Intelligence (AI) Pathology Quality Control Market?

The future expansion of the artificial intelligence (AI) pathology quality control market is anticipated to be driven by the rising need for personalized medicine. This medical strategy involves customizing treatment and prevention methods based on an individual’s distinct genetic profile, lifestyle choices, and environmental factors. The growing uptake of personalized medicine is largely attributed to developments in genomics, facilitating the accurate detection of genetic differences and the creation of customized therapies for patients. Artificial intelligence (AI) pathology quality control improves personalized medicine by providing accurate and reliable diagnostic information, which in turn supports the development of individualized treatment plans. This system minimizes diagnostic mistakes through automated quality assessments, boosting precision and dependability, thereby furthering care that is specific to each patient. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US nonprofit, indicated that the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023. This represents a substantial rise compared to the 12 approvals recorded in 2022. Consequently, the heightened demand for personalized medicine is set to propel the artificial intelligence (AI) pathology quality control market.

What Leading Segments Are Studied In The Artificial Intelligence (AI) Pathology Quality Control Market?

The artificial intelligence (AI) pathology quality control market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software

2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment

3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services

What Trends Are Projected To Support The Growth Of The Artificial Intelligence (AI) Pathology Quality Control Market?

Leading companies within the artificial intelligence (AI) pathology quality control market are focusing on developing sophisticated solutions, particularly advanced AI-powered technologies, to enhance diagnostic accuracy, streamline laboratory workflows, and guarantee the reliability of pathology data. These advanced AI-powered solutions represent next-generation technologies that leverage artificial intelligence to perform intricate tasks with superior accuracy, speed, and efficiency. For instance, in November 2023, PathAI, a US-based biotechnology company, introduced Artifact Detect 1 on its AISight digital pathology platform. This tool automates the detection and quantification of artifacts in whole slide images (WSI), which are morphological features irrelevant to diagnosis and capable of compromising diagnostic accuracy. ArtifactDetect works by automatically pre-screening slides for quality concerns, thereby minimizing misdiagnosis and the need for re-scans, while simultaneously boosting accuracy, laboratory efficiency, and overall operational capacity. This innovation supports timely corrective measures, such as re-staining or re-scanning, ultimately refining the digital workflow and preserving valuable resources for both technicians and pathologists.

Which Leading Companies Dominate The Artificial Intelligence (AI) Pathology Quality Control Market Share?

Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., Gestalt Diagnostics LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-pathology-quality-control-global-market-report

How Does The Artificial Intelligence (AI) Pathology Quality Control Market Perform Across Major Global Regions?

North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) pathology quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Artificial Intelligence (AI) Pathology Quality Control Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28124&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Pathology Quality Control Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Ai In Medical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Ai In Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model